HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease?

AuthorsMark J Kupersmith
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 217 Issue 2 Pg. 123-4 (Feb 15 2004) ISSN: 0022-510X [Print] Netherlands
PMID14706212 (Publication Type: Comment, Editorial)
Chemical References
  • Immunosuppressive Agents
  • Receptors, Cholinergic
  • Pyridostigmine Bromide
  • Prednisone
Topics
  • Disease Progression
  • Drug Administration Schedule
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Myasthenia Gravis (drug therapy)
  • Prednisone (therapeutic use)
  • Pyridostigmine Bromide (therapeutic use)
  • Receptors, Cholinergic (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: